Sandoz Sets Out Expectations For US Humira Competition

Dedicated Q&A With Company Covers US Launch Of Hyrimoz Adalimumab Biosimilar

 
• By David Wallace
  
Company sign reading Sandoz A Novartis Division
Sandoz discusses its recent US adalimumab biosimilar launch • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products